![](/img/cover-not-exists.png)
Development of human bispecific antibodies against CD20/CD55 or CD20/CD59 for the treatment of Burkitt lymphoma
P. Macor, E. Secco, N. Mezzaroba, L. De Maso, P. Durigutto, T. Gaiotto, C. Garrovo, F. Biffi, S. Zorzet, D. Sblattero, F. TedescoVolume:
47
Year:
2010
Language:
english
Pages:
1
DOI:
10.1016/j.molimm.2010.05.264
File:
PDF, 70 KB
english, 2010